Iterum Therapeutics PLC (ITRM) Key Ratios

Stock Card

$0.06

$-0.02 (-23.92%)

As on 02-Jun-2026 09:30EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.4

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	--	--	-85.11	--	--
EBIT	-40.08	-56.59	13.35	11.59	8.95
Net Profit	-37.95	-47.34	11.76	11.35	9.60
EPS	-20.28	35.52	58.25	20.81	14.71
Book Value	--	--	--	--	--

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	TTM	Dec-24	Dec-23
EBIT-Margin	--	--	-6,253.08	--	--
Net Margin	--	--	-6,913.08	--	--
Return on equity	1.22	11,297.23	--	472.61	-355.35
Return on Capital	-88.14	36.34	--	-91.75	-108.62
Return on Assets	-69.50	-106.70	-73.30	-69.93	-82.44
Debt to Equity (x)	--	--	-4.53	-11.16	-2.96

Profitability

View Detailed Peer Comparison

ROCE

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	--	-91.75	-108.62	-64.04	-234.23	680.35
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROE

Profit after tax / Average Net worth * 100

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	--	472.61	-355.35	-113.59	56,347.08	135.44
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROA

-73.30

Profit after tax / Average Total assets * 100

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	-73.30	-69.93	-82.44	-56.12	-147.33	-177.67
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EBIT Margin

-6,253.08

Operating profit (EBIT) / Net Sales * 100

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	-6,253.08	--	--	--	--	--
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Margin

-6,913.08

Net profit / Total Income (Net sales plus other income) * 100

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	-6,913.08	--	--	--	--	--
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Cash Profit Margin

-0.01

(Net profit + Depreciation) / Gross Sales * 100

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	-0.01	--	--	--	--	--
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-85.11

Year on year growth in net sales

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	-85.11	--	--	--	--	-1.00
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EBIT Growth

13.35

Year on year growth in operating profit (EBIT)

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	13.35	39.41	13.03	51.03	-135.87	64.48
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Profit Growth

11.76

Year on year growth in profit after tax

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	11.76	35.44	13.64	51.47	-76.06	49.57
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EPS Growth

58.25

Year on year growth in earnings per share

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	58.25	0.57	0.13	0.52	0.64	0.82
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Book Value Growth

71.93

Year on year growth in book value per share

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	71.93	--	--	--	--	--
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

-4.53

Total debt / Net worth

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	-4.53	-11.16	-2.96	1.08	0.61	-0.95
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Short term debt to equity ratio

-0.04

(Short term borrowings / Net worth)

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	-0.04	-3.54	-0.06	0.01	0.04	-0.14
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Current Ratio

2.13

Current Assets / Current Liabilities and Provisions

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	2.13	1.41	1.89	6.89	6.43	0.51
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Quick Ratio

1.96

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	1.96	--	--	7.09	6.68	0.60
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Interest Coverage

-10.61

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	-10.61	-8.73	-25.44	-17.69	-15.36	-2.40
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

140.00

Debtors outstanding / Net Sales * 100

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	140.00	--	--	--	--	--
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Asset Turnover

0.01

Sales / Average Total Assets

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	0.01	--	--	--	--	--
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Receivable days

Average Debtors / Sales * 365

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	--	--	--	--	--	--
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Inventory Days

Average Inventory / Sales * 365

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	--	--	-386.33	-505.06	-596.14	-13,349.77
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Payable days

Average Creditors / Cost of goods sold * 365

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	--	3,772.57	810.86	370.53	147.04	18,491.63
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

Current share price divided by earning per share in the last twelve months

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	--	-1.41	-0.68	-0.25	-0.06	-0.05
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Price / Book Value

0.43

Current share price divided by book value per share in the latest financial year

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	0.43	-8.54	-4.06	0.40	0.10	-0.05
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Dividend Yield

Dividend per share in the past twelve months divided by current share price

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	--	--	--	--	--	--
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EV/EBITDA

0.55

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	0.55	-2.59	-0.61	0.49	0.55	-0.94
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Market Cap

Current Share price multiplied by latest total number of shares outstanding

Company Name	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Iterum Therapeutics PLC (ITRM)	2	--	--	--	--	--
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly